Xi'an International Medical Investment announces leadership appointments, governance updates

Xi'an International Medical Investment Co., Ltd. held its thirteenth board of directors' seventh meeting on September 8, 2025, approving several key resolutions. Cao Jianan was appointed vice chairman of the thirteenth board of directors and a member of the Strategic Decision Committee. Wang Aiping was appointed as vice president, effective immediately. Fu Qiang, a newly elected employee director, will serve on the Audit Committee. The board also re-elected the executive committee, with Shi Jin as chairwoman, Cao Jianan as vice chairman, and Liu Ruixuan, Sun Wenguo, Wang Aiping, and Ding Zhen as members.

Concurrently, the company held its first extraordinary general meeting of shareholders for 2025 on the same date. Shareholders approved amendments to the "Articles of Association," "Rules of Procedure for Shareholder Meetings," and "Rules of Procedure for Board Meetings." Additionally, the appointment of Cao Jianan as a non-independent director was confirmed, with 99.0586% of all shares and 89.9166% of small and medium investors' shares voting in favor.

Wang Aiping, born in November 1969, holds an MBA and has previous experience with ALL LIFE INC and EAST MILE INVESTMENT LIMITED. She currently serves as vice president and holds 263,211 shares of the company, representing 0.01% of total shares. Her appointment is compliant with relevant laws and regulations.